PRESS RELEASE published on 01/28/2026 at 15:53, 1 month 29 days ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation The Vanguard Group, Inc. discloses ownership of 7.65% stake in Dauch Corporation as per Form 8.3 under Rule 8.3 of the Takeover Code Form 8.3 The Vanguard Group Takeover Code Ownership Disclosure Dauch Corporation
BRIEF published on 01/28/2026 at 15:52, 1 month 29 days ago The Vanguard Group Discloses Position in Just Group plc Takeover Code Securities Disclosure Vanguard Group Stockholding Just Group Plc
BRIEF published on 01/28/2026 at 15:52, 1 month 29 days ago Le groupe Vanguard révèle sa participation dans Just Group plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Information Sur Les Valeurs Mobilières Just Group Plc
PRESS RELEASE published on 01/28/2026 at 15:52, 1 month 29 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 5.08% stake in JTC plc as of 27 Jan 2026. Form 8.3 filing under Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure JTC Plc
BRIEF published on 01/28/2026 at 15:51, 1 month 29 days ago The Vanguard Group Discloses Significant Stake in Picton Property Income Ordinary Shares Takeover Code Vanguard Group Stake Disclosure Picton Property
BRIEF published on 01/28/2026 at 15:51, 1 month 29 days ago Le groupe Vanguard révèle une participation importante dans Picton Property Income Groupe Vanguard Actions Ordinaires Code De Prise De Contrôle Déclaration De Participation Propriété Picton
PRESS RELEASE published on 01/28/2026 at 15:51, 1 month 29 days ago Form 8.3 - The Vanguard Group, Inc.: Glencore plc The Vanguard Group discloses a 4.89% stake in Glencore plc as of 27 January 2026. Additional disclosures for Rio Tinto plc and Rio Tinto Limited are made Vanguard Group Financial Disclosure Stake Disclosure Rio Tinto Glencore Plc
PRESS RELEASE published on 01/28/2026 at 15:50, 1 month 29 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 6.02% interest in Avadel Pharmaceuticals plc through ownership of 5,867,122 ordinary shares as per Form 8.3 to the Irish Takeover Panel The Vanguard Group, Inc. Form 8.3 Irish Takeover Panel Ownership Disclosure Avadel Pharmaceuticals Plc
BRIEF published on 01/28/2026 at 15:50, 1 month 29 days ago The Vanguard Group's Position in Unite Group plc Takeover Code Vanguard Group Shareholding Disclosure Student Accommodation Unite Group Plc
BRIEF published on 01/28/2026 at 15:50, 1 month 29 days ago Position du groupe Vanguard au sein d'Unite Group plc Groupe Vanguard Code De Prise De Contrôle Logements Étudiants Unite Group Plc Déclaration Relative À L'actionnariat
Published on 03/26/2026 at 23:00, 3 hours 22 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 4 hours 17 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 4 hours 22 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 4 hours 22 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 5 hours 22 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 20:48, 5 hours 33 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 7 hours 1 minute ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 7 hours 12 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 7 hours 12 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 8 hours 5 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 8 hours 5 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 8 hours 22 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 8 hours 22 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
